Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 264

Altoida marks $6.3m series A spot

M Ventures has backed the ETH Zurich spinout, which has devised a digital biomarker-driven medical device for diagnosing brain conditions such as Alzheimer's disease.

Jun 3, 2019

Irish universities questioned over staff-spinout links

Ireland's higher education institutions must provide details of staff involvement in university-linked businesses in response to parliamentary concerns.

Jun 3, 2019

Ultrahaptics and Leap Motion to fuse operations for $30m

Bristol-founded haptics platform developer Ultrahaptics is set to absorb Leap Motion's patents and employees, succeeding in a transaction that Apple failed to complete twice.

May 31, 2019

EnteroBiotix instinctively claims $2.5m

Gut microbiome medicine developer EnteroBiotix has been backed by University of Aberdeen in a round that brings its total to $3.2m.

May 31, 2019

Ambisense freshens up funding

Dublin City University pollution monitoring platform developer Ambisense has secured capital from investors including the University Bridge Fund.

May 31, 2019

Retrium retrieves $1.6m

Retrium, which last attracted more than $1m in 2017, was founded by University of Maryland, College Park graduates to market a collaborative platform for software development teams.

May 31, 2019

Verdel charges $289,000

Innovate UK and Longwall Ventures have put up seed capital for Warwick-founded Verdel Instruments, which hopes to commercialise a benchtop-sized lab instrument for conducting two-dimensional mass spectrometry.

May 31, 2019

Rogo Ag cultivates $200,000

Purdue Ag-celerator Fund has injected capital into farming robot developer Rogo Ag, which is aiming to make farming more efficient by reducing errors in soil sampling.

May 31, 2019

GV illuminates Firefly’s series A round

Stanford-StartX Fund-backed Firefly has raised $30m from investors including GV, with the capital earmarked for expansion in regional markets including New York City.

May 31, 2019

Thrive Earlier Detection identifies $110m series A

Thrive will commercialise a blood test for multiple early-stage cancers based on research at Johns Hopkins University, following a series A round backed by Blue Cross and Blue Shield Association.

May 31, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here